Cardiovascular disease in spondyloarthritis: a narrative review of risk factors and the effect of treatments.

IF 5.2 2区医学 Q1 RHEUMATOLOGY Current opinion in rheumatology Pub Date : 2023-12-21 DOI:10.1097/bor.0000000000000999

Rouhin Sen, Liron Caplan, Maria I Danila

引用次数: 0

Abstract

This review summarizes the recent evidence available regarding the epidemiology of cardiovascular disease in spondyloarthritis (SpA), including the effect of disease modifying drugs on cardiovascular risk.

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

脊柱关节炎的心血管疾病：风险因素和治疗效果综述。

本综述总结了有关脊柱关节炎（SpA）心血管疾病流行病学的最新证据，包括疾病调节药物对心血管风险的影响。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Current opinion in rheumatology 医学-风湿病学

CiteScore

9.70

自引率

2.00%

发文量

审稿时长

6-12 weeks

期刊介绍： A high impact review journal which boasts an international readership, Current Opinion in Rheumatology offers a broad-based perspective on the most recent and exciting developments within the field of rheumatology. Published bimonthly, each issue features insightful editorials and high quality invited reviews covering two or three key disciplines which include vasculitis syndromes, medical physiology and rheumatic diseases, crystal deposition diseases and rheumatoid arthritis. Each discipline introduces world renowned guest editors to ensure the journal is at the forefront of knowledge development and delivers balanced, expert assessments of advances from the previous year.

期刊最新文献

Autoantibodies as putative biomarkers and triggers of cell dysfunctions in systemic sclerosis. Imaging in vasculitis. Polymyalgia rheumatica and giant cell arteritis: diagnosis and management. Inclusion body myositis: an update. VEXAS syndrome: an adult-onset autoinflammatory disorder with underlying somatic mutation.